RxDoctor Payments Data

Timothy Beard, MD

Surgery · Bend, ORNPI 1831200740

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (55.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Heron Therapeutics, Inc. accounts for 61.1% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2021 at $84,292 and has fallen 61.1% since, to $32,826 in 2025. Among surgery clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$211,256in general payments, 2019–2025

Across 290 payments — averaging $728.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Heron Therapeutics, Inc.$129K
  • Vertex$43K
  • Trevena, Inc.$29K
  • Merck$7K
  • Medtronic$3K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$68
  • plus $268 from 13 others
$189,745in research payments, 2019–2025

Across 22 payments — averaging $8624.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Heron Therapeutics, Inc.$179K
  • Vertex$9K
  • AbbVie$1K

What the payments were for

  • Consulting fees$55,17026%
  • Speaking & faculty fees$116,64155%
  • Travel & lodging$35,22117%
  • Food & beverage$4,2242%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$211,256 in reported general payments places this provider in the 95th percentile of 386 surgery providers in Oregon.

See all surgery providers in Oregon

Medicare billing

Part B allowed, 2024
$183,160
Medicare patients
571
Services billed
834

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl11$13

Paid to pharmacies, not to this prescriber.

Other surgery in Bend

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →